1. Home
  2. Analysis
  3. Cefotetan
  4. Haemoglobin-decreased

Cefotetan and Haemoglobin decreased - a phase IV clinical study of FDA data

Summary:

Haemoglobin decreased is reported as a side effect among people who take Cefotetan (cefotetan disodium), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Demerol, and have Device related infection.

The phase IV clinical study analyzes which people have Haemoglobin decreased when taking Cefotetan. It is created by eHealthMe based on reports of 223 people who have side effects when taking Cefotetan from the FDA, and is updated regularly.

What is Cefotetan?

Cefotetan has active ingredients of cefotetan disodium. eHealthMe is studying from 223 Cefotetan users. Check the latest studies of Cefotetan.

What is Haemoglobin decreased?

Haemoglobin decreased is found to be associated with 2,408 drugs and 3,129 conditions by eHealthMe. Check the latest studies of Haemoglobin decreased.

On Jul, 14, 2026

223 people reported to have side effects when taking Cefotetan.
Among them, 11 people (4.93%) have Haemoglobin decreased.

Could Cefotetan cause Haemoglobin decreased?

Among these 11 people:

How long have people been on Cefotetan when they have Haemoglobin decreased? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Haemoglobin decreased when taking Cefotetan? *

  • female: 72.73 %
  • male: 27.27 %

What is the age of people who have Haemoglobin decreased when taking Cefotetan? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 9.09 %
  • 40-49: 45.45 %
  • 50-59: 9.09 %
  • 60+: 36.36 %

What are other drugs people take besides Cefotetan? *

  1. Vistaril: 3 people, 27.27%
  2. Duragesic: 3 people, 27.27%
  3. Lorazepam: 3 people, 27.27%
  4. Morphine: 3 people, 27.27%
  5. Parnate: 3 people, 27.27%
  6. Premarin: 3 people, 27.27%
  7. Fentanyl: 3 people, 27.27%
  8. Provera: 3 people, 27.27%
  9. Seroquel: 3 people, 27.27%
  10. Demerol: 3 people, 27.27%

What are other side effects people have besides Haemoglobin decreased? *

  1. Red Blood Cell Count Decreased: 5 people, 45.45%
  2. Haematocrit Decreased: 5 people, 45.45%
  3. Difficulty In Walking: 4 people, 36.36%
  4. Hypertensive Crisis: 4 people, 36.36%
  5. Chest Pain: 4 people, 36.36%
  6. Ventricular Hypertrophy (enlargement of ventricles (lower chambers) in the heart): 4 people, 36.36%
  7. Neck Pain: 4 people, 36.36%
  8. Liver Function Tests Nos Abnormal: 4 people, 36.36%
  9. Libido Decreased (loss of interest in sex): 4 people, 36.36%
  10. Ascites (accumulation of fluid in the abdominal cavity): 4 people, 36.36%

What are the existing conditions these people have? *

  1. Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 1 person, 9.09%
  2. Device Related Infection: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cefotetan and have Haemoglobin decreased?

- Check whether Haemoglobin decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefotetan:

Haemoglobin decreased treatments and more:

How severe was Haemoglobin decreased and when was it recovered:

Expand to all the drugs that have ingredients of cefotetan disodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefotetan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemoglobin decreased:

Browse all the conditions that are associated with Haemoglobin decreased:

How the study uses the data?

The study uses data from the FDA. It is based on cefotetan disodium (the active ingredients of Cefotetan) and Cefotetan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.